HUTCHMED (China) Limited HCM
Set alert
13.27 USD +0.12 +0.91%
At close · Nov 2
13.27 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
13.22 Day range 13.46
9.77 52-week range 16.33
- YTD
- -0.45%
- 1 year
- -9.60%
- Open
- 13.23
- Prev close
- 13.15
- Mkt cap
- 2.31B
- Vol
- 47.96K
- Avg vol
- 66.77K
- EPS
- 0.10
- P/E
- 132.70
- Div yield
- 0.00%
More statistics
- Low
- 13.22
- High
- 13.46
- Forward P/E
- 51.19
- Beta
- 0.49
- Short ratio
- 4.66
- Inst. own
- 2.58%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 4, 2027
- 50-d avg
- 13.65
- 200-d avg
- 13.22
- 1y target
- 20.59
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 20.59 +55.2% upside
Now 13.27
- Target (low)
- 13.60
- Target (mean)
- 20.59
- Target (high)
- 33.27
Ratings (0m) 12 10 buy · 2 hold · 0 sell
- Strong buy1
- Buy9
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 12
- 1 month ago 13
- 2 months ago 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.22185 | 0.02 – 0.401 | 2.62 | -91.5% | 626.35M | +14.2% | 6 |
| Next year | 0.25921 | 0.07432 – 0.621 | 0.22185 | +16.8% | 699.47M | +11.7% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 23, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 7, 2026 | B of A Securities | Maintained | Buy | Buy |
| Mar 10, 2026 | B of A Securities | Maintained | Buy | Buy |
| Sep 22, 2025 | Morgan Stanley | Downgrade | Equal-Weight | Underweight |
| Jul 22, 2025 | B of A Securities | Maintained | Buy | Buy |
| Aug 1, 2024 | Goldman Sachs | Maintained | Neutral | Neutral |
| Nov 24, 2023 | Deutsche Bank | Upgrade | Hold | Buy |
| Nov 10, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| Sep 5, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jul 24, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Aug 9, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Aug 2, 2022 | Goldman Sachs | Maintained | — | Neutral |
| Sep 22, 2021 | Goldman Sachs | Downgrade | Buy | Neutral |
| Aug 3, 2021 | Jefferies | Initiated | — | Buy |
| Mar 13, 2020 | Cantor Fitzgerald | Initiated | — | Overweight |
| Feb 20, 2020 | Goldman Sachs | Initiated | — | Buy |
| Nov 19, 2019 | CLSA | Initiated | — | Buy |
| Mar 4, 2019 | Deutsche Bank | Initiated | — | Buy |
| Oct 17, 2017 | Canaccord Genuity | Maintained | — | Buy |
| Apr 11, 2016 | Stifel | Initiated | — | Buy |
| Apr 11, 2016 | Canaccord Genuity | Initiated | — | Buy |
| Apr 11, 2016 | B of A Securities | Initiated | — | Buy |